ID: ALA594610

Max Phase: Preclinical

Molecular Formula: C14H12N2S

Molecular Weight: 240.33

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  NCc1c(-c2cccnc2)sc2ccccc12

Standard InChI:  InChI=1S/C14H12N2S/c15-8-12-11-5-1-2-6-13(11)17-14(12)10-4-3-7-16-9-10/h1-7,9H,8,15H2

Standard InChI Key:  VAWXHMNFIJSEPD-UHFFFAOYSA-N

Associated Targets(non-human)

Intestinal alkaline phosphatase 300 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 240.33Molecular Weight (Monoisotopic): 240.0721AlogP: 3.42#Rotatable Bonds: 2
Polar Surface Area: 38.91Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.53CX LogP: 2.40CX LogD: 0.32
Aromatic Rings: 3Heavy Atoms: 17QED Weighted: 0.75Np Likeness Score: -1.14

References

1. Li L, Chang L, Pellet-Rostaing S, Liger F, Lemaire M, Buchet R, Wu Y..  (2009)  Synthesis and evaluation of benzo[b]thiophene derivatives as inhibitors of alkaline phosphatases.,  17  (20): [PMID:19781951] [10.1016/j.bmc.2009.08.048]

Source